Welcome : Guest

Alder BioPharmaceuticals, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Alder BioPharmaceuticals, Inc., which is principally involved in Clinical-Stage Biopharmaceuticals Business. Illustrated with 45 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-63681
Price: $2250
Company Type: Public
Pages: 47
Date: November 2016
Market Data Tables: 45

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Migraine Drugs......3
Table 1: Migraine Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Prescriptions for Amerge Generic (Naratriptan), Imitrex Generic (Sumatriptan), Maxalt Generic (Rizatriptan), Relpax (Pfizer), and Zomig Generic (Zolmitriptan)......3
Monoclonal Antibodies......4
Table 2: Antiviral Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Antiviral Drugs, Monoclonal Antibodies, Vaccines and Others......4
Table 3: Biotechnology Drugs by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Cell Therapy, Gene Therapy, Monoclonal Antibodies (MAB), Recombinant Hormones and Proteins, Vaccines, and Others......5
Table 4: Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics, Monoclonal Antibodies and Other Classes......6
Table 5: Therapeutic Development Market by Product Worldwide (2015) - Percentage Share Breakdown by Volume for Cell Therapy, Monoclonal Antibodies, Vaccines and Others......7
Table 6: Therapeutic Biologics Market by Type in China (2015) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibodies (MAb), Nerve GF, Somatropin, and Others......8
Inflammatory Bowel Disease (IBD)......9
Table 7: Inflammatory Bowel Disease (IBD) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Anti-Inflammatory, Biologics, and Immunomodulatory......9
Table 8: Specialty Inflammatory Conditions Drugs Benefit Market by Category in the US (2015) - Percentage Share Breakdown by Value for Medical Benefit and Pharmacy Benefit......10
Congenital Adrenal Hyperplasia (CAH)......11
Table 9: No. of Patients with Adrenal Insufficiency by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Congenital adrenal hyperplasia (CAH), and Paediatric Adrenal Insufficiency (Ins Congenital Adrenal Hyperplasia), and Other......11
Table 10: No. of Patients with Paediatric Adrenal Insufficiency (including Congenital Adrenal Hyperplasia) by Region Worldwide (2015) - Percentage Share Breakdown by Volume for Europe, and US......12
Table 11: Adrenal Insufficiency Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Congenital Adrenal Hyperplasia (CAH), Paediatric Adrenal Insufficiency (Inc. Congenital Adrenal Hyperplasia), and Others......13
Table 12: Adult Adrenal Insufficiency (inc. Congenital Adrenal Hyperplasia) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, and US......14
Table 13: Adult Congenital Adrenal Hyperplasia (CAH) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, and US......15
Table 14: Paediatric Adrenal Insufficiency (inc Congenital Adrenal Hyperplasia) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, and US......16
Table 15: Congenital Adrenal Hyperplasia (CAH) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, and US......17
Table 16: Cortisol Deficiency in Adults Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Adult Adrenal Hyperplasia (AI), and Adult Congenital Adrenal Hyperplasia (CAH)......18
Table 17: Cortisol Deficiency in Paediatrics Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Paediatric Adrenal Insufficiency (AI), Paediatric Congenital Adrenal Hyperplasia (CAH)......19
Table 18: Cortisol Deficiency Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Adult (inc. Congenital Adrenal Hyperplasia), and Paediatric Adrenal Insufficiency (inc. Congenital Adrenal Hyperplasia)......20
Table 19: No. of Adult Patients with Cortisol Deficiency by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Adult Adrenal Insufficiency (AI), and Adult Congenital Adrenal Hyperplasia (CAH)......21
Table 20: No. of Paediatric Patients with Cortisol Deficiency by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Paediatric Adreno Insufficiency (AI), Paediatric Congenital Adrenal Hyperplasia (CAH)......22
Table 21: No. of Patients with Adult Adrenal Insufficiency (inc. Congenital Adrenal Hyperplasia) by Region Worldwide (2015) - Percentage Share Breakdown by Volume for Europe, and US......23
Table 22: No. of Patients with Adult Congenital Adrenal Hyperplasia (CAH) by Region Worldwide (2015) - Percentage Share Breakdown by Volume For Europe, and US......24
Table 23: No. of Patients with Congenital Adrenal Hyperplasia (CAH) by Region Worldwide (2015) - Percentage Share Breakdown by Volume for Europe, and US......25
Table 24: No. of Patients with Paediatric Adrenal Insufficiency (Inc. Congenital Adrenal Hyperplasia) by Region Worldwide (2015) - Percentage Share Breakdown by Volume for Europe, and US......26
Table 25: No. of Patients with Paediatric Congenital Adrenal Hyperplasia (CAH) by Region Worldwide (2015) - Percentage Share Breakdown by Volume for Europe, and US......27
Table 26: Paediatric Adrenal Insufficiency (Inc. Congenital Adrenal Hyperplasia) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, and US......28
Table 27: Paediatric Congenital Adrenal Hyperplasia (CAH) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, and US......29
Table 28: No. of Patients with Adrenal Insufficiency by Type in Europe (2015) - Percentage Share Breakdown by Volume for Congenital Adrenal Hyperplasia (CAH), Paediatric Adrenal Insufficiency (inc Congenital Adrenal Hyperplasia), and Others......30
Table 29: Adrenal Insufficiency Market by Type in Europe (2015) - Percentage Share Breakdown by Value for Congenital Adrenal Hyperplasia (CAH), Paediatric Adrenal Insufficiency (inc. Congenital Adrenal Hyperplasia), and Others......31
Table 30: Cortisol Deficiency in Adults Market by Type in Europe (2015) - Percentage Share Breakdown by Value for Adult Adrenal Hyperplasia (AI), and Adult Congenital Adrenal Hyperplasia (CAH)......32
Table 31: Cortisol Deficiency in Paediatrics Market by Type in Europe (2015) - Percentage Share Breakdown by Value for Paediatric Adrenal Insufficiency (AI), Paediatric Congenital Adrenal Hyperplasia (CAH)......33
Table 32: Cortisol Deficiency Market by Category in Europe (2015) - Percentage Share Breakdown by Value for Adult (inc. Congenital Adrenal Hyperplasia), and Paediatric Adrenal Insufficiency (inc. Congenital Adrenal Hyperplasia)......34
Table 33: No. of Adult Patients with Cortisol Deficiency by Type in Europe (2015) - Percentage Share Breakdown by Volume for Adult Adrenal Insufficiency (AI), and Adult Congenital Adrenal Hyperplasia (CAH)......35
Table 34: No. of Paediatric Patients with Cortisol Deficiency by Type in Europe (2015) - Percentage Share Breakdown by Volume for Paediatric Adrenal Insufficiency (AI), Paediatric Congenital Adrenal Hyperplasia (CAH)......36
Table 35: No. of Patients with Adrenal Insufficiency by Type in the US (2015) - Percentage Share Breakdown by Volume for Congenital Adrenal Hyperplasia (CAH), and Paediatric Adrenal Insufficiency (including Congenital Adrenal Hyperplasia), and Others......37
Table 36: Adrenal Insufficiency Market by Type in the US (2015) - Percentage Share Breakdown by Value for Congenital Adrenal Hyperplasia (CAH), Paediatric Adrenal Insufficiency (Inc Congenital Adrenal Hyperplasia), and Others......38
Table 37: Cortisol Deficiency in Adults Market by Type in the US (2015) - Percentage Share Breakdown by Value for Adult Adrenal Insufficiency (AI), and Adult Congenital Adrenal Hyperplasia (CAH)......39
Table 38: Cortisol Deficiency in Paediatrics Market by Type in the US (2015) - Percentage Share Breakdown by Value for Paediatric Adrenal Insufficiency (AI), Paediatric Congenital Adrenal Hyperplasia (CAH)......40
Table 39: Cortisol Deficiency Market by Category in the US (2015) - Percentage Share Breakdown by Value for Adult (inc. Congenital Adrenal Hyperplasia), and Paediatric Adrenal Insufficiency (inc. Congenital Adrenal Hyperplasia)......41
Table 40: No. of Adult Patients with Cortisol Deficiency by Type in the US (2015) - Percentage Share Breakdown by Volume for Adult Adrenal Insufficiency (AI), and Adult Congenital Adrenal Hyperplasia (CAH)......42
Table 41: No. of Paediatric Patients with Cortisol Deficiency by Type in the US (2015) - Percentage Share Breakdown by Volume for Paediatric Adreno Insufficiency (AI), Paediatric Congenital Adrenal Hyperplasia (CAH)......43
Monoclonal Antibodies......44
Table 42: Monoclonal Antibodies Market by Drugs Worldwide (2015) - Percentage Share Breakdown by Value for Avastin, Crestor, Enbrel, Humira, Lantus, Remicade and Others......44
Table 43: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......45
Rheumatoid Arthritis......46
Table 44: Rheumatoid Arthritis Market by Product Type Worldwide (2015) – Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and Others......46
Anti-Inflammatory Biologics......47
Table 45: Market Shares of Leading Anti-Inflammatory Biologic Brands Worldwide (2015) - Percentage Share Breakdown by Value for Actemra, Enbrel, Humira, Remicade and Others......47